Kailera Therapeutics, Inc. (KLRA)

21.47 -1.00 (-4.45%) USD  |  NASDAQ  |  May 08, 16:00
21.57 +0.10 (+0.47%) After-Hours: 20:00
More

Kailera Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Liminatus Pharma, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. --
Veracyte, Inc. Upgrade
Insight Molecular Diagnostics, Inc. Upgrade